- Report
- January 2025
- 240 Pages
Global
From €4309EUR$4,799USD£3,669GBP
- Report
- May 2025
- 189 Pages
Global
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- May 2025
- 182 Pages
Global
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- May 2025
- 185 Pages
Global
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- February 2025
- 240 Pages
Global
From €2415EUR$2,690USD£2,057GBP
- Report
- May 2025
- 189 Pages
Global
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- March 2025
- 200 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- February 2025
- 200 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- February 2025
- 200 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- April 2025
- 175 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- April 2025
- 200 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- January 2025
- 175 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- June 2025
- 264 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 367 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- January 2025
- 135 Pages
Global
From €2693EUR$2,999USD£2,293GBP
- Drug Pipelines
- August 2024
- 150 Pages
Global
From €2504EUR$2,789USD£2,132GBP
- Report
- August 2024
- 233 Pages
Global
From €7138EUR$7,950USD£6,079GBP
- Report
- June 2024
- 140 Pages
Asia Pacific
From €3474EUR$3,869USD£2,958GBP
- Report
- June 2024
- 140 Pages
Latin America
From €3474EUR$3,869USD£2,958GBP
- Report
- June 2024
- 140 Pages
Europe
From €3474EUR$3,869USD£2,958GBP

Topiramate is a drug used to treat a variety of neurological conditions, including epilepsy, migraine, and bipolar disorder. It is classified as an anticonvulsant and antiepileptic drug, and is used to reduce the frequency of seizures and to prevent migraine headaches. It is also used to treat bipolar disorder, as it can help to reduce the frequency and severity of manic episodes. Topiramate is a member of the Central Nervous System (CNS) drug class, which includes drugs used to treat neurological conditions.
Topiramate is available in both generic and brand-name formulations, and is available in a variety of dosage forms, including tablets, capsules, and oral solutions. It is typically taken once or twice daily, depending on the condition being treated. Side effects of topiramate include dizziness, drowsiness, and nausea.
The market for topiramate is highly competitive, with a number of major pharmaceutical companies offering the drug. Some of the companies in the market include Pfizer, GlaxoSmithKline, Johnson & Johnson, and Novartis. Show Less Read more